- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Panitumumab – March 2013
Panitumumab, concentrate solution for infusion, 100 mg in 5mL & 400 mg in 20 mL, Vectibix®
Last updated
8 November 2023